PubMed

Idiopathic membranous nephropathy in pediatric patients: presentation, response to therapy, and long-term outcome.

Chen A, Frank R, Vento S, Crosby V, Chandra M, Gauthier B, Valderrama E, Trachtman H.

BMC Nephrol. 2007 Aug 6;8:11.PMID: 17683621 [PubMed - indexed for MEDLINE]Related articlesFree article

Short-term outcomes of severe lupus nephritis in a cohort of predominantly African-American children.

Lau KK, Jones DP, Hastings MC, Gaber LW, Ault BH.

Pediatr Nephrol. 2006 May;21(5):655-62. Epub 2006 Mar 29.PMID: 16570203 [PubMed - indexed for MEDLINE]Related articles

Membranous glomerulonephritis: treatment response and outcome in children.

Valentini RP, Mattoo TK, Kapur G, Imam A.

Pediatr Nephrol. 2009 Feb;24(2):301-8. Epub 2008 Oct 10.PMID: 18846392 [PubMed - indexed for MEDLINE]Related articles

Mycophenolate mofetil and cyclosporine therapy in membranous nephropathy.

Cattran DC.

Semin Nephrol. 2003 May;23(3):272-7. Review.PMID: 12838495 [PubMed - indexed for MEDLINE]Related articles

The remission of nephrotic syndrome with cyclosporin treatment does not attenuate the progression of idiopathic membranous nephropathy.

Goumenos DS, Kalliakmani P, Tsakas S, Sotsiou F, Vlachojannis JG.

Clin Nephrol. 2004 Jan;61(1):17-24.PMID: 14964453 [PubMed - indexed for MEDLINE]Related articles

Prognosis and risk factors for idiopathic membranous nephropathy with nephrotic syndrome in Japan.

Shiiki H, Saito T, Nishitani Y, Mitarai T, Yorioka N, Yoshimura A, Yokoyama H, Nishi S, Tomino Y, Kurokawa K, Sakai H; Research Group on Progressive Renal Diseases in Japan.

Kidney Int. 2004 Apr;65(4):1400-7.PMID: 15086481 [PubMed - indexed for MEDLINE]Related articles

ACE inhibition improves glomerular size selectivity in patients with idiopathic membranous nephropathy and persistent nephrotic syndrome.

Ruggenenti P, Mosconi L, Vendramin G, Moriggi M, Remuzzi A, Sangalli F, Remuzzi G.

Am J Kidney Dis. 2000 Mar;35(3):381-91.PMID: 10692263 [PubMed - indexed for MEDLINE]Related articles

Mycophenolate mofetil monotherapy in membranous nephropathy: a 1-year randomized controlled trial.

Dussol B, Morange S, Burtey S, Indreies M, Cassuto E, Mourad G, Villar E, Pouteil-Noble C, Karaaslan H, Sichez H, Lasseur C, Delmas Y, Nogier MB, Fathallah M, Loundou A, Mayor V, Berland Y.

Am J Kidney Dis. 2008 Oct;52(4):699-705. Epub 2008 Jun 30.PMID: 18585835 [PubMed - indexed for MEDLINE]Related articles

Does immunosuppression with prednisolone and azathioprine alter the progression of idiopathic membranous nephropathy?

Ahuja M, Goumenos D, Shortland JR, Gerakis A, Brown CB.

Am J Kidney Dis. 1999 Sep;34(3):521-9.PMID: 10469864 [PubMed - indexed for MEDLINE]Related articles

Cyclosporin A treatment for idiopathic membranous nephropathy.

Yao X, Chen H, Wang Q, Tang Z, Hu W, Yin G, Liu Z, Li L.

Chin Med J (Engl). 2001 Dec;114(12):1305-8.PMID: 11793859 [PubMed - indexed for MEDLINE]Related articlesFree article

Introduction of a cyclophosphamide-based treatment strategy and the risk of ESRD in patients with idiopathic membranous nephropathy: a nationwide survey in the Netherlands.

Hofstra JM, Wetzels JF.

Nephrol Dial Transplant. 2008 Nov;23(11):3534-8. Epub 2008 Jun 17.PMID: 18559961 [PubMed - indexed for MEDLINE]Related articles

Treatment of renal failure in idiopathic membranous nephropathy with azathioprine and prednisolone.

Brown JH, Douglas AF, Murphy BG, Hill CM, McNamee PT, Nelson WE, Doherty CC.

Nephrol Dial Transplant. 1998 Feb;13(2):443-8.PMID: 9509460 [PubMed - indexed for MEDLINE]Related articles

Short- and long-term efficacy of oral cyclophosphamide and steroids in patients with membranous nephropathy and renal insufficiency. Study Group.

Branten AJ, Wetzels JF.

Clin Nephrol. 2001 Jul;56(1):1-9.PMID: 11499653 [PubMed - indexed for MEDLINE]Related articles

The prognosis of biopsy-proven lupus nephritis in chinese patients: long term follow-up of 86 cases.

Shen K, Yu Y, Tang Z, Liu Z, Li L.

Chin Med J (Engl). 1997 Jul;110(7):502-7.PMID: 9594205 [PubMed - indexed for MEDLINE]Related articles

Mycophenolate mofetil treatment for therapy-resistant glomerulopathies.

Sahin GM, Sahin S, Kantarci G, Ergin H.

Nephrology (Carlton). 2007 Jun;12(3):285-8.PMID: 17498124 [PubMed - indexed for MEDLINE]Related articles

Reduction of proteinuria with mycophenolate mofetil in predominantly membranous lupus nephropathy.

Karim MY, Pisoni CN, Ferro L, Tungekar MF, Abbs IC, D'Cruz DP, Khamashta MA, Hughes GR.

Rheumatology (Oxford). 2005 Oct;44(10):1317-21. Epub 2005 Jul 27.PMID: 16049051 [PubMed - indexed for MEDLINE]Related articlesFree article

Cytotoxic therapy for membranous nephropathy and renal insufficiency: improved renal survival but high relapse rate.

du Buf-Vereijken PW, Branten AJ, Wetzels JF; Membranous Nephropathy Study Group.

Nephrol Dial Transplant. 2004 May;19(5):1142-8. Epub 2004 Feb 19.PMID: 14993502 [PubMed - indexed for MEDLINE]Related articlesFree article

Prednisolone and azathioprine in membranous nephropathy: a 10-year follow-up study.

Goumenos DS, Ahuja M, Davlouros P, El Nahas AM, Brown CB.

Clin Nephrol. 2006 May;65(5):317-23.PMID: 16724651 [PubMed - indexed for MEDLINE]Related articles

Clinical and morphological prognostic factors in membranous nephropathy: significance of focal segmental glomerulosclerosis.

Dumoulin A, Hill GS, Montseny JJ, Meyrier A.

Am J Kidney Dis. 2003 Jan;41(1):38-48.PMID: 12500220 [PubMed - indexed for MEDLINE]Related articles

[Mycophenolate mofetil in high risk IgA glomerulonephritis]

Frutos MA, López V, Alférez MJ, Aranda P.

Nefrologia. 2005;25(4):387-92. Spanish. PMID: 16231504 [PubMed - indexed for MEDLINE]Related articles